A Role of Complement in the Pathogenic Sequelae of Mouse Neonatal Germinal Matrix Hemorrhage
Authors:
- Mohammed AlshareefMAMohammed Alshareef
- Khalil MallahKMKhalil Mallah
- Tyler VasasTVTyler Vasas
- Ali AlawiehAAAli Alawieh
- Davis BoruckiDBDavis Borucki
- Christine CouchCCChristine Couch
- Jonathan CutroneJCJonathan Cutrone
- Chelsea ShopeChelsea Shope
- Ramin EskandariRERamin Eskandari
- Stephen TomlinsonSTStephen Tomlinson
Open Access
- 9 March 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (6) , 2943
Abstract
Germinal matrix hemorrhage (GMH) is a devastating disease of infancy that results in intraventricular hemorrhage, post-hemorrhagic hydrocephalus (PHH), periventricular leukomalacia, and neurocognitive deficits. There are no curative treatments and limited surgical options. We developed and characterized a mouse model of GMH based on the injection of collagenase into the subventricular zone of post-natal pups and utilized the model to investigate the role of complement in PHH development. The site-targeted complement inhibitor CR2Crry, which binds deposited C3 complement activation products, localized specifically in the brain following its systemic administration after GMH. Compared to vehicle, CR2Crry treatment reduced PHH and lesion size, which was accompanied by decreased perilesional complement deposition, decreased astrocytosis and microgliosis, and the preservation of dendritic and neuronal density. Complement inhibition also improved survival and weight gain, and it improved motor performance and cognitive outcomes measured in adolescence. The progression to PHH, neuronal loss, and associated behavioral deficits was linked to the microglial phagocytosis of complement opsonized neurons, which was reversed with CR2Crry treatment. Thus, complement plays an important role in the pathological sequelae of GMH, and complement inhibition represents a novel therapeutic approach to reduce the disease progression of a condition for which there is currently no treatment outside of surgical intervention.Keywords
Funding Information
- U.S. Department of Veterans Affairs (BX004256, RX001141, IK6BX005235)
- National Institutes of Health (T32AI132164)
- Neurosurgery Research and Education Foundation (NREF 2020-21)
This publication has 58 references indexed in Scilit:
- A Novel Preclinical Model of Germinal Matrix Hemorrhage Using Neonatal Rats2011
- Role of Microglia in NeurotraumaNeurotherapeutics, 2010
- Chemokine CCL18 predicts intraventricular hemorrhage in very preterm infantsAnnals of Medicine, 2010
- Crosstalk pathways between Toll-like receptors and the complement systemTrends in Immunology, 2010
- Annual Summary of Vital Statistics: 2007Pediatrics, 2010
- The Diagnosis, Management, and Postnatal Prevention of Intraventricular Hemorrhage in the Preterm NeonateClinics in Perinatology, 2008
- Persistent motor deficit following infusion of autologous blood into the periventricular region of neonatal ratsExperimental Neurology, 2006
- Reactive Astrocytes in Neural Repair and ProtectionThe Neuroscientist, 2005
- Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infectionJournal of Clinical Investigation, 2005
- The role of the complement system in traumatic brain injuryBrain Research Reviews, 1998